ACSL3–PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression
Tumor progression
DOI:
10.1126/sciadv.abb9200
Publication Date:
2020-10-30T23:15:17Z
AUTHORS (10)
ABSTRACT
Pharmacological inhibition of PAI-1 strongly enhances chemo- and immunotherapeutic response against PDAC.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (60)
CITATIONS (44)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....